Cargando…
Candidate Gene Study of TRAIL and TRAIL Receptors: Association with Response to Interferon Beta Therapy in Multiple Sclerosis Patients
TRAIL and TRAIL Receptor genes have been implicated in Multiple Sclerosis pathology as well as in the response to IFN beta therapy. The objective of our study was to evaluate the association of these genes in relation to the age at disease onset (AAO) and to the clinical response upon IFN beta treat...
Autores principales: | López-Gómez, Carlos, Pino-Ángeles, Almudena, Órpez-Zafra, Teresa, Pinto-Medel, María Jesús, Oliver-Martos, Begoña, Ortega-Pinazo, Jesús, Arnáiz, Carlos, Guijarro-Castro, Cristina, Varadé, Jezabel, Álvarez-Lafuente, Roberto, Urcelay, Elena, Sánchez-Jiménez, Francisca, Fernández, Óscar, Leyva, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639207/ https://www.ncbi.nlm.nih.gov/pubmed/23658636 http://dx.doi.org/10.1371/journal.pone.0062540 |
Ejemplares similares
-
TRAIL/TRAIL Receptor System and Susceptibility to Multiple Sclerosis
por: López-Gómez, Carlos, et al.
Publicado: (2011) -
TRAIL and TRAIL receptors splice variants during long-term interferon β treatment of patients with multiple sclerosis: evaluation as biomarkers for therapeutic response
por: López-Gómez, Carlos, et al.
Publicado: (2016) -
Cross-reactivity of antibodies against interferon beta in multiple sclerosis patients and interference of the JAK-STAT signaling pathway
por: Hurtado-Guerrero, Isaac, et al.
Publicado: (2017) -
Trailing TRAIL Resistance: Novel Targets for TRAIL Sensitization in Cancer Cells
por: Trivedi, Rachana, et al.
Publicado: (2015) -
Global methylation correlates with clinical status in multiple sclerosis patients in the first year of IFNbeta treatment
por: Pinto-Medel, María Jesús, et al.
Publicado: (2017)